Increased Levels of IL-17, IL-23, MIP-1α, MCP-1 and Global Leukocytes in Fibromyalgia Patients

References

• Dadabhoy D, Crofford LJ, Spaeth M, Russell IJ, Clauw DJ: Biology and therapy of fibromyalgia. Evidence-based biomarkers for fibromyalgia syndrome. Arthritis Res Ther 10: 211, 2008
   PubMed Web of Science ®Google Scholar
• Wolfe F, Hauser W: Fibromyalgia diagnosis and diagnostic criteria. Ann Med 43: 495–502, 2011
   PubMed Web of Science ®Google Scholar
• Sarzi-Puttini P, Atzeni FD, Franco M, Buskila D, Alciati A, Giacomelli C, Rossi A, Bazzichi L: Dysfunctional syndromes and fibromyalgia: A 2012 critical digest. Clin Exp Rheumatol 30: 143–151, 2012
   PubMed Web of Science ®Google Scholar
• Carvalho LS, Correa H, Silva GC, Campos FS, Baiao FR, Ribeiro LS, Faria AM, d'Avila Reis D: May genetic factors in fibromyalgia help to identify patients with differentially altered frequencies of immune cells? Clin Exp Immunol 154: 346–352, 2008
   PubMed Web of Science ®Google Scholar
• Pernambuco AP, Schetino LP, Alvim CC, Murad CM, Viana RS, Carvalho LS, Reis DA: Increased levels of IL-17A in patients with fibromyalgia. Clin Exp Rheumatol 31(6 Suppl 79): S60–S63, 2013
   Web of Science ®Google Scholar
• Al-Allaf AW, Ottewell L, Pullar T: The prevalence and significance of positive antinuclear antibodies in patients with fibromyalgia syndrome: 2–4 years' follow-up. Clin Rheumatol 21: 472–477, 2002
   Web of Science ®Google Scholar
• Nishikai M, Tomomatsu S, Hankins RW, Takagi S, Miyachi K, Kosaka S, Akiya K: Autoantibodies to a 68/48 kDa protein in chronic fatigue syndrome and primary fibromyalgia: A possible marker for hypersomnia and cognitive disorders. Rheumatology (Oxford) 40: 806–810, 2001
   PubMed Web of Science ®Google Scholar
• Togo F, Natelson BH, Adler GK, Ottenweller JE, Goldenberg DL, Struzik ZR, Yamamoto Y: Plasma cytokine fluctuations over time in healthy controls and patients with fibromyalgia. Exp Biol Med (Maywood) 234: 232–240, 2009
   Web of Science ®Google Scholar
• Kaufmann I, Eisner C, Richter P, Huge V, Beyer A, Chouker A, Schelling G, Thiel M: Lymphocyte subsets and the role of TH1/TH2 balance in stressed chronic pain patients. Neuroimmunomodulation 14: 272–280, 2007
   PubMed Web of Science ®Google Scholar
• Kotter I, Neuscheler D, Gunaydin I, Wernet D, Klein R: Is there a predisposition for the development of autoimmune diseases in patients with fibromyalgia? Retrospective analysis with long term follow-up. Rheumatol Int 27: 1031–1039, 2007
   Web of Science ®Google Scholar
• Bellato E, Marini E, Castoldi F, Barbasetti N, Mattei L, Bonasia DE, Blonna D: Fibromyalgia syndrome: Etiology, pathogenesis, diagnosis, and treatment. Pain Res Treatment 2012: 426130, 2012
   PubMedGoogle Scholar
• Bazzichi L, Sernissi F, Consensi A, Giacomelli C, Sarzi-Puttini P: Fibromyalgia: A critical digest of the recent literature. Clin Exp Rheumatol 29: S1–11, 2011
   Web of Science ®Google Scholar
• Amsen D, de Visser KE, Town T: Approaches to determine expression of inflammatory cytokines. Methods Mol Biol 511: 107–142, 2009
   Google Scholar
• Nascimento MLP: Linfocitopenias: Valores normais para leucócitos totaise a relação com os monócitos. São Paulo: NewsLab editor; 2008
   Google Scholar
• Fonseca A, Bagnoli V, Arie W, Azevedo Neto R, Couto Jr E, Baracat E: Dados demográficos, epidemiológicos e clínicos de mulheres brasileiras climatéricas, Casa Leitura Médica, São Paulo, 2010
   Google Scholar
• Molnar I, Bohaty I, Somogyine-Vari E: High prevalence of increased interleukin-17A serum levels in postmenopausal estrogen deficiency. Menopause 21: 749–752, 2014
   PubMed Web of Science ®Google Scholar
• Yasui T, Saijo A, Uemura H, Tsuchiya N, Yuzurihara M, Kase Y, Irahara M: Interleukin-7 is associated with monocyte chemoattractant protein-1 and soluble E-selectin levels in peripheral blood of newly post-menopausal women. J Reprod Immunol 81: 97–102, 2009
   PubMed Web of Science ®Google Scholar
• Sumarac-Dumanovic M, Stevanovic D, Ljubic A, Jorga J, Simic M, Stamenkovic-Pejkovic D, Starcevic V, et al: Increased activity of interleukin-23/interleukin-17 proinflammatory axis in obese women. Int J Obes (Lond) 33: 151–156, 2009
   PubMed Web of Science ®Google Scholar
• Sturgeon JA, Darnall BD, Zwickey HL, Wood LJ, Hanes DA, Zava DT, Mackey SC: Proinflammatory cytokines and DHEA-S in women with fibromyalgia: Impact of psychological distress and menopausal status. J Pain Res 7: 707–716, 2014
   PubMed Web of Science ®Google Scholar
• Francischetti I, Moreno JB, Scholz M, Yoshida WB: Os leucócitos e a resposta inflamatória na lesão de isquemia-reperfusão. Braz J Cardiovasc Surg 25: 575–584, 2010
   Google Scholar
• Souza EJdRe, Nogueira-Machado JA, Silva FdCLe,Chaves MM, Costa DC: Avaliação da produção de espécies reativas de oxigênio por granulócitos de sangue periférico de pacientes com fibromialgia primária. Rev Brasil Reumatol 43: 337–342, 2003
   Google Scholar
• Macedo JA, Hesse J, Turner JD, Ammerlaan W, Gierens A, Hellhammer DH, Muller CP: Adhesion molecules and cytokine expression in fibromyalgia patients: Increased l-selectin on monocytes and neutrophils. J Neuroimmunol 188: 159–166, 2007
   Web of Science ®Google Scholar
• Neeson PJ, Thurlow PJ, Jamieson GP, Bradley C: Lymphocyte-facilitated tumour cell adhesion to endothelial cells: The role of high affinity leucocyte integrins. Pathology 35: 50–55, 2003
   PubMed Web of Science ®Google Scholar
• Abdalla AO, Kiaii S, Hansson L, Rossmann ED, Jeddi-Tehrani M, Shokri F, Osterborg A, et al: Kinetics of cytokine gene expression in human CD4+ and CD8+ T-lymphocyte subsets using quantitative real-time PCR. Scand J Immunol 58: 601–606, 2003
   Web of Science ®Google Scholar
• Korn T, Bettelli E, Oukka M, Kuchroo VK: IL-17 and Th17 cells. Annu Rev Immunol 27: 485–517, 2009
   PubMed Web of Science ®Google Scholar
• Hillyer P, Larche MJ, Bowman EP, McClanahan TK, de Waal Malefyt R, Schewitz LP, Giddins G, et al: Investigating the role of the interleukin-23/-17A axis in rheumatoid arthritis. Rheumatology (Oxford) 48: 1581–1589, 2009
   PubMed Web of Science ®Google Scholar
• Deshmane SL, Kremlev S, Amini S, Sawaya BE: Monocyte chemoattractant protein-1 (MCP-1): An overview. J Interferon Cytokine Res 29: 313–326, 2009
   PubMed Web of Science ®Google Scholar
• Feng J, Zhang Z, Li W, Shen X, Song W, Yang C, Chang F, et al: Missense mutations in the MEFV gene are associated with fibromyalgia syndrome and correlate with elevated IL-1beta plasma levels. PLoS One 4: e8480, 2009
   Web of Science ®Google Scholar
• Kim CF, Moalem-Taylor G: Interleukin-17 contributes to neuroinflammation and neuropathic pain following peripheral nerve injury in mice. J Pain 12: 370–383, 2011
   Web of Science ®Google Scholar
• Shankar E, Vykhovanets EV, Vykhovanets OV, Maclennan GT, Singh R, Bhaskaran N, Shukla S, Gupta S: High-fat diet activates pro-inflammatory response in the prostate through association of Stat-3 and NF-kappaB. Prostate 72: 233–243, 2012
   Web of Science ®Google Scholar
• Chen DY, Chen YM, Chen HH, Hsieh CW, Lin CC, Lan JL: Increasing levels of circulating Th17 cells and interleukin-17 in rheumatoid arthritis patients with an inadequate response to anti-TNF-alpha therapy. Arthritis Res Ther 13: R126, 2011
   PubMed Web of Science ®Google Scholar
• Kurtuncu M, Tuzun E, Turkoglu R, Petek-Balci B, Icoz S, Pehlivan M, Birisik O, et al: Effect of short-term interferon-beta treatment on cytokines in multiple sclerosis: Significant modulation of IL-17 and IL-23. Cytokine 59: 400–402, 2012
   PubMed Web of Science ®Google Scholar
• Goser S, Ottl R, Brodner A, Dengler TJ, Torzewski J, Egashira K, Rose NR, et al: Critical role for monocyte chemoattractant protein-1 and macrophage inflammatory protein-1alpha in induction of experimental autoimmune myocarditis and effective anti-monocyte chemoattractant protein-1 gene therapy. Circulation 112: 3400–3407, 2005
   PubMed Web of Science ®Google Scholar
• Cua DJ, Tato CM: Innate IL-17-producing cells: The sentinels of the immune system. Nat Rev Immunol 10: 479–489, 2010
   PubMed Web of Science ®Google Scholar
• Zhang L, Li YG, Li YH, Qi L, Liu XG, Yuan CZ, Hu NW, et al: Increased frequencies of Th22 cells as well as Th17 cells in the peripheral blood of patients with ankylosing spondylitis and rheumatoid arthritis. PLoS One 7: e31000, 2012
   PubMed Web of Science ®Google Scholar
• Mieliauskaite D, Dumalakiene I, Rugiene R, Mackiewicz Z: Expression of IL-17, IL-23 and their receptors in minor salivary glands of patients with primary Sjogren's syndrome. Clin Dev Immunol 2012: 187258, 2012
   Google Scholar
• Yoshizaki A, Yanaba K, Iwata Y, Komura K, Ogawa A, Muroi E, Ogawa F, et al: Elevated serum interleukin-27 levels in patients with systemic sclerosis: Association with T cell, B cell and fibroblast activation. Ann Rheumat Dis 70: 194–200, 2011
   PubMed Web of Science ®Google Scholar
• Romero-Sanchez C, Jaimes DA, Londono JD, Avila J, Castellanos JE, Bello JM, Bautista W, Valle-Onate R: Association between Th-17 cytokine profile and clinical features in patients with spondyloarthritis. Clin Exp Rheumatol 29: 828–834, 2011
   Web of Science ®Google Scholar
• Meng X, Zhang Y, Lao L, Saito R, Li A, Backman CM, Berman BM, et al: Spinal interleukin-17 promotes thermal hyperalgesia and NMDA NR1 phosphorylation in an inflammatory pain rat model. Pain 154: 294–305, 2013
   Web of Science ®Google Scholar
• Chen Y, Jiang T, Chen P, Ouyang J, Xu G, Zeng Z, Sun Y: Emerging tendency towards autoimmune process in major depressive patients: A novel insight from Th17 cells. Psychiatry Res 188: 224–230, 2011
   PubMed Web of Science ®Google Scholar
• Liu Y, Ho RC, Mak A: The role of interleukin (IL)-17 in anxiety and depression of patients with rheumatoid arthritis. Int J Rheumat Dis 15: 183–187, 2012
   PubMed Web of Science ®Google Scholar
• Izcue A, Hue S, Buonocore S, Arancibia-Carcamo CV, Ahern PP, Iwakura Y, Maloy KJ, Powrie F: Interleukin-23 restrains regulatory T cell activity to drive T cell-dependent colitis. Immunity 28: 559–570, 2008
   PubMed Web of Science ®Google Scholar
• Toussirot E: The IL23/Th17 pathway as a therapeutic target in chronic inflammatory diseases. Inflammat Allergy Drug Targets 11: 159–168, 2012
   PubMedGoogle Scholar
• Welsby I, Goriely S: Regulation of interleukin-23 expression in health and disease. Adv Exp Med Biol 941: 167–189, 2016
   Web of Science ®Google Scholar
• Rios-Navarro C, de Pablo C, Collado-Diaz V, Orden S, Blas-Garcia A, Martinez-Cuesta MA, Esplugues JV, Alvarez A: Differential effects of anti-TNF-alpha and anti-IL-12/23 agents on human leukocyte–endothelial cell interactions. Eur J Pharmacol 765: 355–365, 2015
   PubMed Web of Science ®Google Scholar
• Snyder-Cappione JE, Tincati C, Eccles-James IG, Cappione AJ, Ndhlovu LC, Koth LL, Nixon DF: A comprehensive ex vivo functional analysis of human NKT cells reveals production of MIP1-alpha and MIP1-beta, a lack of IL-17, and a Th1-bias in males. PLoS One 5: e15412, 2010
   Web of Science ®Google Scholar
• Zhang Z, Cherryholmes G, Mao A, Marek C, Longmate J, Kalos M, Amand RP, Shively JE: High plasma levels of MCP-1 and eotaxin provide evidence for an immunological basis of fibromyalgia. Exp Biol Med (Maywood) 233: 1171–1180, 2008
   Web of Science ®Google Scholar
• Tomioka R, Matsui M: Biomarkers for multiple sclerosis. Intern Med 53: 361–365, 2014
   PubMed Web of Science ®Google Scholar
• Littlejohn G: Neurogenic neuroinflammation in fibromyalgia and complex regional pain syndrome. Nat Rev Rheumatol 11: 639–648, 2015
   PubMed Web of Science ®Google Scholar
• Bote ME, Garcia JJ, Hinchado MD, Ortega E: Inflammatory/stress feedback dysregulation in women with fibromyalgia. Neuroimmunomodulation 19: 343–351, 2012
   PubMed Web of Science ®Google Scholar
• Melgarejo E, Medina MA, Sanchez-Jimenez F, Urdiales JL: Monocyte chemoattractant protein-1: A key mediator in inflammatory processes. Int J Biochem Cell Biol 41: 998–1001, 2009
   PubMed Web of Science ®Google Scholar
• White FA, Feldman P, Miller RJ: Chemokine signaling and the management of neuropathic pain. Mol Interv 9: 188–195, 2009
   PubMedGoogle Scholar
• Svensson CI: Interleukin-6: A local pain trigger? Arthritis Res Ther 12: 145, 2010
   Web of Science ®Google Scholar
• Ang DC, Moore MN, Hilligoss J, Tabbey R: MCP-1 and IL-8 as pain biomarkers in fibromyalgia: A pilot study. Pain Med 12: 1154–1161, 2011
   PubMed Web of Science ®Google Scholar
• Zhou L, Ivanov II, Spolski R, Min R, Shenderov K, Egawa T, Levy DE, et al: IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat Immunol 8: 967–974, 2007
   PubMed Web of Science ®Google Scholar
• Mease PJ, Dundon K, Sarzi-Puttini P: Pharmacotherapy of fibromyalgia. Best Pract Res Clin Rheumatol 25: 285–297, 2011
   PubMed Web of Science ®Google Scholar